Quantitative structure property relationship studies for predicting plasma protein binding properties of Cephalosporins

Authors

  • Anu Grover Faculty of Pharmacy, Pacific Academy of Higher Education and Research University, Udaipur, India
  • Manish Grover University Institute of Pharmaceutical sciences, Panjab University, Chandigarh, India
  • Komal Sharma Department of pharmacology, B N Institute of Pharmaceutical Sciences, Udaipur, India

DOI:

https://doi.org/10.56511/JIPBS.2016.v3.i02.pp94-102

Abstract

Cephalosporins are of key clinical importance for treatment of bacterial infections. In the past decade, many cephalosporins have been synthesized and evaluated for antibacterial activity. These cephalosporins, with broad spectra of activity and high stability against various β-lactamases such as cefixime, cefteram pivoxil, and cefpodoxime proxetil, have been developed and introduced in clinical practice. Efforts to synthesize more compounds for better activity are still on. It is very important that the antibiotic has favorable pharmacokinetic properties [absorption, distribution, metabolism, excretion (ADME)]. Hence, predicting pharmacokinetic parameters, of a new molecule, in an early stage of drug design, is of as high importance as the activity of the compound. With rapid advances in computation power of machines and availability of experimental data, these ADME properties can now be better predicted by using suitable computational methods. In present study, an attempt has been made to derive quantitative relationships between structure of cephalosporins and one of the important pharmacokinetic property, serum plasma protein binding.

           

Keywords:

Cephalosporins, ADME, QSPR

Downloads

Download data is not yet available.

References

Kuchar, M., QSAR in Design of Bioactive Compounds: Proceedings of the 2nd Telesymposium on Medicinal Chemistry, Telesymposia proceedings. January 1992: J.R. Prous Science.

Ivanciuc, O., 3D QSAR Models. , in QSPR/QSAR Studies by Molecular Descriptors, M.V. Diudea, Editor, Nova Science: Huntington, NY. 2001; 233-280.

Reich, S.H., M.A. Fuhry, D. Nguyen, M.J. Pino, K.M. Welsh, S. Webber, C.A. Janson, S.R. Jordan, D.A. Matthews, W.W. Smith, and et al., Design and synthesis of novel 6,7imidazotetrahydroquinoline inhibitors of thymidylate synthase using iterative protein crystal structure analysis. J Med Chem 1992; 35(5):847-58.

Kuntz, I.D., E.C. Meng, and B.K. Shoichet, Structure-Based Molecular Design. Accounts of Chemical Research 1994; 27(5):117.

Ariens, E.J., Drug Design. NY: Academic Press, A subsidiary of harcourt Brace Jovanovich, 1971.

Cronin and T.D. Mark, Quantitative Structure – Activity Relationships (QSARs) – Applications and Methodology, in Recent Advances in QSAR Studies, T. Puzyn, J. Leszczynski, and M.T. Cronin, Editors, Springer Netherlands 2010; 3-11.

Bajot, F., The Use of Qsar and Computational Methods in Drug Design, in Recent Advances in QSAR Studies, T. Puzyn, J. Leszczynski, and M.T. Cronin, Editors., Springer Netherlands 2010; 261-282.

Kerns, E.H., L. Di, E.H. Kerns, and L. Di, Chapter 2 - Advantages of Good Drug-like Properties. Academic Press: San Diego 2008; 6.

Ritschel, W.A., Handbook of basic pharmacokinetics including clinical applications. Fourth ed., Hamilton: Drug Intelligence Publications 1992; 531-549.

Bergan, T., Pharmacokinetic properties of cephalosporins. Drugs 1987; 34(2):89-104.

Vozeh, S., O. Schmidlin, and W. Taeschner, Pharmacokinetic drug data. Clin Pharmacokin 1988; 15:254-282.

Pfeffer, M., A. Jackson, J. Ximenes, and J.P. De Memezes, Comparative human oral clinical pharmacology of cefadroxil, cepalexin, and cephradine. Antimicrobial Ag. Chemother 1977; 11(2):331-338.

Stoeckel, K., M. P. J., R. Brandt, H. PlozzaNotterbrock, and W.H. Ziegler, Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clin. Pharmacol. Ther. 1981; 29(5):650-657.

Noble, J.T. and M. Barza, Pharmacokinetic properties of the newer cephalosporins: A valid basis for drug selection? Drugs 1985; 30:175-181.

Barbhaiya, R.H., U.A. Shukla, C.R. Gleason, W.C. Shyu, R.B. Wilber, and K.A. Pittman, Comarison of cefprozil and cefaclor pharmacokinetics and tissue penetration. Antimicrobial Ag. Chemother. 1990; 34(6):1204-1209.

Gobburu, J.V. and W.H. Shelver, Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks. J Pharm Sci. 1995; 84(7):862-865.

Apichartpichean, R., T. Hasegawa, M. Nadai, T. Kuzuya, and T. Nabeshima, Structurepharmacokinetic relationships among the N1, N3-alkylxanthines in rats. Journal of Pharmacy & Pharmacology 1991; 43:262269.

Kaul, S. and W.A. Ritschel, Quantitative structure--pharmacokinetic relationship of a series of sulfonamides in the rat. Eur J Drug Metab Pharmacokinet 1990; 15(3):211-7.

Gombar, C.T., R.M. Demarinis, M. Wise, and B.A. Mico, Pharmacokinetics of a series of 6-chloro-2,3,4,5-tetrahydro-3-substituted1H3-benzazepines in rats. Determination of quantitative structure-pharmacokinetic relationships. Drug Metab Dispos 1988; 16(3):367-72.

Watari, N., Y. Sugiyama, N. Kaneniwa, and M. Hiura, Prediction of hepatic first-pass metabolism and plasma levels following intravenous and oral administration of barbiturates in the rabbit based on quantitative structure-pharmacokinetic relationships. Journal of Pharmacokinetics & Biopharmaceutics 1988; 16:279-301.

Hinderling, P.H., O. Schmidlin, and J.K. Seydel, Quantitative relationships between structure and pharmacokinetics of betaadrenoceptor blocking agents in man. Journal of Pharmacokinetics & Biopharmaceutics 1984; 12:263-287.

Sharples, D., Factors affecting the binding of tricyclic tranquilizers and antidepressants to human serum albumin. J Pharm Pharmacol 1976; 28:100-105.

Markin, R.S., W.J. Murray, and H. Boxenbaum, Quantitative structure-activity study on human pharmacokinetic parameters of benzodiazepines using the graph theoretical approach. Pharm Res. 1988; 5(4):201-8.

Reed, K., K. Mereish, and B. Jensen, Quantitative relationsps between structre and pharmacokinetic paramters usign molecular connectivity chi indices I: substituted 2-sulfapyridines. J Pharm Sci. 1984; 73(2):237-239.

Seydel, J.K., D. Trettin, H.P. Cordes, O. Wassermann, and M. Malyusz, Quantitative structure-pharmacokinetic relationships derived on antibacterial sulfonamides in rats and its comparison to quantitative structure-activity relationships. J Med Chem. 1980; 23(6):607-613.

Published

05-04-2016
Statistics
263 Views | 221 Downloads

How to Cite

Anu Grover, Manish Grover, and Komal Sharma. “Quantitative Structure Property Relationship Studies for Predicting Plasma Protein Binding Properties of Cephalosporins”. Journal of Innovations in Pharmaceutical and Biological Sciences, vol. 3, no. 2, Apr. 2016, pp. 94-102, doi:10.56511/JIPBS.2016.v3.i02.pp94-102.

Issue

Section

Research Article